{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06003348",
            "orgStudyIdInfo": {
                "id": "2023-0339"
            },
            "organization": {
                "fullName": "University of Texas Southwestern Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones",
            "officialTitle": "Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones",
            "therapeuticArea": [
                "Nephrology and Renal Diseases"
            ],
            "study": "hydroxycitrate-a-novel-therapy-for-calcium-phosphate-urinary-stones"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-13",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-05-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-08-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-14",
            "studyFirstSubmitQcDate": "2023-08-14",
            "studyFirstPostDateStruct": {
                "date": "2023-08-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-11",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Naim Maalouf",
                "investigatorTitle": "Professor, Internal Medicine",
                "investigatorAffiliation": "University of Texas Southwestern Medical Center"
            },
            "leadSponsor": {
                "name": "University of Texas Southwestern Medical Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "This study tests whether hydroxycitrate, a molecule closely related to citrate, can reduce calcium phosphate stone recurrence.",
            "detailedDescription": "In this double-blind, placebo-controlled, randomized, crossover study, each participant will undergo 4 phases of study, with the order randomized by a blocked randomization scheme. The 4 phases will be Placebo, Super CitriMax (hydroxycitrate) OHCit low dose, OHCit standard dose, or Potassium Citrate. Randomization will be stratified based on sex, concomitant thiazide use, and concomitant alkali use.\n\nEach phase will be 1 week in duration, during which subjects will take assigned study medications. A minimum 1-week washout period will be imposed between phases. During the first 2 days of each phase, subjects will be instructed to adhere to a prescribed diet. On the last 5 days of each phase, subjects will be kept on a constant metabolic diet. Use of metabolic diet is essential to eliminate confounders that could occur from changes in dietary intake across phases. During the final two study days (days 6-7), two 24-hr urines will be collected for urine biochemistry and crystallization studies. Fasting blood will be obtained at the end of the last urine collection.\n\nStudy Medications: Subjects will receive three tablets twice daily during each phase. These will consist of either placebo, Potassium Citrate (KCit), or Super CitriMax (OHCit). Study tablets will be prepared by a compounding pharmacy, with placebo tablets similar in appearance and size to the active medication tablets."
        },
        "conditionsModule": {
            "conditions": [
                "Calcium Phosphate Kidney Stones"
            ],
            "keywords": [
                "Urolithiasis",
                "Calcium phosphate",
                "Citrate",
                "Acid-base"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "In this double-blind, placebo-controlled, randomized, crossover study, each participant will undergo 4 phases of study, with the order randomized by a blocked randomization scheme. The 4 phases will be Placebo, Super CitriMax (OHCit) low dose, Super CitriMax (OHCit) standard dose, or Potassium Citrate. Randomization will be stratified based on sex, concomitant thiazide use, and concomitant alkali use.",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 25,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Potassium Citrate (Urocit\u00ae-K)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Potassium Citrate KCit 10 mEq 2 tabs, twice daily and Placebo 1 tab, twice daily Total Daily Dose: Citrate 40 mEq/d",
                    "interventionNames": [
                        "Drug: Potassium Citrate"
                    ]
                },
                {
                    "label": "Super CitriMax; OHCit-standard dose",
                    "type": "EXPERIMENTAL",
                    "description": "Super CitriMax 7 mEq 3 tabs, twice daily Total Daily Dose: OHCit 42 mEq/d",
                    "interventionNames": [
                        "Dietary Supplement: OHCit- standard dose"
                    ]
                },
                {
                    "label": "Super CitriMax; OHCit-low dose",
                    "type": "EXPERIMENTAL",
                    "description": "Super CitriMax 7 mEq 2 tabs, twice daily And Placebo 1 tab, twice daily Total Daily Dose: OHCit 28 mEq/d",
                    "interventionNames": [
                        "Dietary Supplement: OHCit- low dose"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo 3 tablets twice daily Total Daily Dose: None",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "OHCit- standard dose",
                    "description": "Hydroxycitrate Over-the-counter supplement, not FDA approved or regulated.",
                    "armGroupLabels": [
                        "Super CitriMax; OHCit-standard dose"
                    ],
                    "otherNames": [
                        "Super Citrimax"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Potassium Citrate",
                    "description": "10 mEq Extended-release tablets for oral use",
                    "armGroupLabels": [
                        "Potassium Citrate (Urocit\u00ae-K)"
                    ],
                    "otherNames": [
                        "Urocit\u00ae-K"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                },
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "OHCit- low dose",
                    "description": "Hydroxycitrate Over-the-counter supplement, not FDA approved or regulated.",
                    "armGroupLabels": [
                        "Super CitriMax; OHCit-low dose"
                    ],
                    "otherNames": [
                        "Super Citrimax"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Formation product (FP) for Calcium Phosphate",
                    "description": "FP is obtained by adding increasing amounts of Calcium Chloride (CaCl2) to a series of urine aliquots maintained at constant pH for 2 hours, and is identified by the point at which calcium phosphate (CaP) precipitates as detected by an absorbance microplate reader.\n\nCalculated supersaturation using \\[Calcium\\] and \\[Phosphate\\] at that point represents FP.",
                    "timeFrame": "After 1 week of treatment"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Crystal growth of Calcium Phosphate",
                    "description": "We will assess crystal growth (CG) of CaP after seeding urine with a small amount of brushite (0.25 mg/ml urine) and incubating at 37\u00b0C for 3 hours (representing steady state) under constant stirring. A decrement in \\[Calcium\\]\u00d7\\[Phosphate\\] after seeding signifies crystal growth, while a \\[Calcium\\]\u00d7\\[Phosphate\\] increment represents crystal dissolution.",
                    "timeFrame": "After 1 week of treatment"
                },
                {
                    "measure": "Calcium Phosphate supersaturation",
                    "description": "Supersaturation of calcium phosphate will be assessed by Joint Expert Speciation System (JESS).",
                    "timeFrame": "After 1 week of treatment"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n- Calcium Phosphate stone formers\n\nExclusion Criteria:\n\n* History of recurrent urinary tract infections\n* Chronic diarrhea\n* Estimated Glomerular Filtration Rate (eGFR) \\< 45 ml/min/1.73 m2\n* History of primary hyperparathyroidism\n* Hypokalemia\n* Hyperkalemia\n* Pregnancy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "21 Years",
            "maximumAge": "99 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "NAIM M MAALOUF, MD",
                    "role": "CONTACT",
                    "phone": "214/648-2954",
                    "email": "naim.maalouf@utsouthwestern.edu"
                },
                {
                    "name": "Miranda King",
                    "role": "CONTACT",
                    "phone": "2146482117",
                    "email": "Miranda.King@utsouthwestern.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "NAIM M MAALOUF",
                    "affiliation": "University of Texas Southwestern Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "UT Southwestern Medical Center",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390-8885",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Naim M Maalouf, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007669",
                    "term": "Kidney Calculi"
                },
                {
                    "id": "D000014545",
                    "term": "Urinary Calculi"
                },
                {
                    "id": "D000052878",
                    "term": "Urolithiasis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002137",
                    "term": "Calculi"
                },
                {
                    "id": "D000020763",
                    "term": "Pathological Conditions, Anatomical"
                },
                {
                    "id": "D000053040",
                    "term": "Nephrolithiasis"
                },
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10693",
                    "name": "Kidney Calculi",
                    "asFound": "Kidney Stone",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27126",
                    "name": "Nephrolithiasis",
                    "relevance": "LOW"
                },
                {
                    "id": "M27103",
                    "name": "Urolithiasis",
                    "asFound": "Urinary Stone",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17295",
                    "name": "Urinary Calculi",
                    "asFound": "Urinary Stone",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5399",
                    "name": "Calculi",
                    "relevance": "LOW"
                },
                {
                    "id": "M22519",
                    "name": "Pathological Conditions, Anatomical",
                    "relevance": "LOW"
                },
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019357",
                    "term": "Potassium Citrate"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004232",
                    "term": "Diuretics"
                },
                {
                    "id": "D000045283",
                    "term": "Natriuretic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000005100",
                    "term": "Expectorants"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21334",
                    "name": "Potassium Citrate",
                    "asFound": "Proprietary",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "M21320",
                    "name": "Citric Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M1837",
                    "name": "Sodium Citrate",
                    "relevance": "LOW"
                },
                {
                    "id": "M7411",
                    "name": "Diuretics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8243",
                    "name": "Expectorants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T382",
                    "name": "Citrate",
                    "asFound": "Type 2",
                    "relevance": "HIGH"
                },
                {
                    "id": "T397",
                    "name": "Hydroxycitric Acid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "NaAg",
                    "name": "Natriuretic Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                },
                {
                    "abbrev": "AnCoag",
                    "name": "Anticoagulants"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                }
            ]
        }
    },
    "hasResults": false
}